440.20€
0.00€ (0.00%)
End-of-day quote: 08/12/2022
XTRA:SRT

Sartorius (SRT)

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide.

If you are interested in SRT stock information, you might also be interested in competitors like OM:GETI B.

With a P/E ratio of 26.67, the stock appears relatively expensive compared to its index ^AW01 at the moment.

The market capitalization of Sartorius is currently at 29.00€ B. This places it among the high capitalized companies.

With one share of Sartorius investors achieved a dividend of 1.23€. This results in a very low dividend yield of 0.28%. In the last 14 years, the annual dividend has risen constantly.

For the risk analysis, the low beta factor should be noted, which is currently at a value of 0.67. The price of the stock XTRA:SRT is therefore subject to moderate fluctuations in relation to the overall market.

62% of SRT Stocks is owned by insiders.

For Wall Street analysts, a price target of 382.92€ is currently considered realistic.

XTRA:SRT has a 52 week range of 293.30€ - 631.60€ and is currently trading around 440.20€.

The low short sale ratio indicated that the value might increase in the foreseeable future.

5
Neutral
1
2
3
4
5
6
7
8
9
10
1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
52.1
Market Cap
29.00B
LT Debt/Cap
0.05%
Price-to-book Ratio
0
Earnings
10/19/2022
Dividend
1.23€
Div Yld
0.28%
Dividend Growth
14 Years
Beta
0.67
Short Interest
0.00%
Forecast 1Y
40.86%
Analyst Price Target
382.92€
LTG 5Y
33.02%
52 week range
293.30€ - 631.60€
Country